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Diagnostic Criteria of Vascular Dementia in CADASIL
Sarah Benisty, MD; Karen Hernandez, MSc; Anand Viswanathan, MD, PhD; Sonia Reyes, MSc;
Annie Kurtz, MSc; Michael O’Sullivan, PhD; Marie-Germaine Bousser, MD;
Martin Dichgans, MD, PhD; Hugues Chabriat, MD, PhD
Background and Purpose—Subcortical ischemic vascular dementia (SIVD) is a major subtype of vascular dementia
(VaD). Recently, the diagnostic criteria of VaD have been modified to encompass this entity. Application of these
criteria in CADASIL, a genetic model of SIVD, may help to better assess their significance. The aim of this study was
to compare different sets of diagnostic criteria of VaD in a population of CADASIL patients.
Methods—Different sets of diagnostic criteria of VaD (DSMIV, ICD10, standard NINDS-AIREN, modified NINDS-
AIREN for SIVD) were applied to 115 CADASIL patients. Diagnosis of VaD was made through 2 steps: (1) diagnosis
of dementia and (2) association of dementia to lesions of vascular origin. The percentage of patients satisfying the
different sets and the concordance between these criteria was analyzed.
Results—At least 1 set of criteria was satisfied for diagnosis in 29 subjects with dementia. In this group of patients, the
sensitivity of the DSM IV, ICD 10, and standard NINDS-AIREN criteria for VaD was, respectively, 79%, 72%, and
45%. In contrast, the sensitivity of the NINDS-AIREN criteria for SIVD was 90%. The incomplete sensitivity of these
last criteria was related to the absence of focal signs in some patients. The neuroimaging criteria were satisfied in all
patients with dementia.
Conclusions—The modified NINDS-AIREN criteria of SIVD are the most sensitive VaD criteria in CADASIL. Among
these criteria, the neuroimaging criteria, although poorly specific to dementia, have a complete sensitivity. In contrast,
focal signs were inconstant in CADASIL patients with dementia. (Stroke. 2008;39:838-844.)
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Vascular dementia (VaD) is the second most commoncause of dementia after Alzheimer disease.1 In clinical
research, various criteria are proposed for diagnosis of VaD,
particularly in therapeutic trials. They are based on 2 major
requirements: (1) clinical diagnosis of dementia and (2)
determination of its vascular origin. The latter requirement is
most problematic because of the frequent overlap between
cerebrovascular and degenerative disorders, particularly in
the elderly. Four sets of criteria have been essentially used for
diagnosis of VaD: Diagnostic and Statistical Manual of
Mental Disorders, fourth edition (DSM IV),2 Alzheimer’s
Disease Diagnostic and Treatment Centers (ADDTC),3 Inter-
national Statistical Classification of Diseases, 10th revision
(ICD 10),4 and National Institute of Neurological Disorders
and Stroke Association Internationale Pour la Recherche et
l’Enseignement en Neurosciences (NINDS-AIREN) criteria.5
Previous analyses of these criteria showed that they were not
all equivalent6–9 In addition, because these criteria were
proposed to cover the wide spectrum of VaD, none of them is
able to discriminate the main subtypes of vascular dementia
such as multi-infarct dementia, strategic infarct dementia, or
subcortical ischemic vascular dementia (SIVD).1
SIVD may represent one of the most common forms of
VaD. It can be caused by various types of small vessel disease
that lead to lacunar infarcts and white matter lesions restricted
to subcortical areas.10 This entity was considered homoge-
nous enough to require specific diagnostic criteria. Recently,
a set of research criteria derived from the NINDS-AIREN
criteria of vascular dementia was proposed.11 These criteria
rely on both clinical and radiological data. Further evaluation
of their sensitivity and specificity is now needed.
In contrast to sporadic small vessel diseases frequently
detected during aging in association with degenerative disor-
ders, CADASIL (cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy) is a rare
disease with onset occurring between age 40 and 50 years.12
CADASIL is caused by mutations of the Notch 3 gene on
chromosome 19.13 It is recognized as the most frequent
hereditary cause of SIVD and as a model of “pure” VaD. In
CADASIL, brain MRI shows widespread white matter le-
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sions associated with lacunar infarcts of variable extent or
number and developing from the third decade.14 The main
clinical manifestations include attacks of migraine with aura,
recurrent subcortical stroke, mood disturbances, and a pro-
gressive cognitive decline leading to dementia.12 The cogni-
tive profile in CADASIL is characteristic of VaD and similar
to that reported in sporadic SIVD.15 Because symptoms in
CADASIL develop several decades before the onset of
common degenerative diseases, confounding by concomi-
tant medical conditions is considerably reduced. Therefore,
CADASIL patients with dementia can be used as a reference
population to understand the limitations of diagnostic criteria
currently used for VaD or recently proposed for SIVD.
In the present study, we applied different sets of diagnostic
criteria for VaD in a large group of CADASIL patients to
determine in this population: (1) the sensitivity of the these
diagnostic criteria with respect to all demented patients
detected in the cohort; (2) the sensitivity of subcriteria used
for attribution of the vascular origin; and (3) the sensitivity of
the modified NINDS-AIREN criteria for the diagnosis of
SIVD.
Methods
Subjects
One hundred fifteen CADASIL patients followed-up in Lariboisiere
Hospital (Paris, France) were included in the study. Their mean age
was 53.711.7 years, the sex ratio (male/female) was 1.01, and
education level was from 3 to 7 (maximal). Diagnosis was confirmed
by identification of a typical mutation in the Notch 3 gene. Informed
consent was obtained from each subject or from a close relative if the
subject was too severely disabled to give written consent. The study
was approved by an independent ethics committee.
Clinical Data
Clinical and demographic data were collected at the time of inclusion
with detailed baseline neurological examination including the assess-
ment of presence or absence of gait abnormalities, Parkinsonian
syndrome, pyramidal signs, sensory deficit, visual field defect,
dysphagia, dysarthria, or ocular palsy.
Neuropsychological Evaluation
Neuropsychological evaluation was performed in patients without
severe depression after evaluation by the psychologist. Global
cognitive function was assessed by the Mini-Mental State Examina-
tion16 and Mattis Dementia Rating Scale (from 0 to 144 [best
score]).17 Memory was assessed by an explicit verbal memory test
adapted from the Grober and Buschke procedure.18,19 Executive
functions were assessed by subtest of the Wechsler Adult Intelli-
gence Scale-Revised (Similarities and Block Design),20 the Trail
Making Test B,21 the Wisconsin Card Sorting test (revised version
by Nelson),22 and both semantic and letter verbal fluency. Except for
the Wisconsin test, performances in each test were converted into z
scores using normative data reported from the literature and data
from healthy populations.19 In addition to these neuropsychological
tests, activities of daily living and disability attributable to cognitive
impairment were assessed based on a French translation of Lawton’s
scale of Instrumental Activities of Daily Living (IADL).23 The
scoring of this scale was based on the interview of the patient or a
close relative. Each of 8 IADL (ability to handle finances, to use the
telephone, mode of transport, responsibility for own medication, etc)
was assessed according to a 3- to 5-grade scale. Then the patients
were given a score of 1 if they were considered nonrestricted or were
given a score of 0 if they were restricted (score 0). A global score
ranging from 0 to 8 was obtained.
Magnetic Resonance Imaging
MRI scans were obtained by the use of a 1.5-T system (Signa
General Electric Medical Systems) as already reported.24 The extent
of white matter lesions was visually assessed on FLAIR images
based on the recommendations specified in the criteria and described
further. The number and location of lacunar infarcts, defined as
hypointense foci of diameter 3 mm on T1 scans or on FLAIR
images, were also recorded when they were not located in areas with
high prevalence of widened perivascular spaces.25,26
Diagnosis of Vascular Dementia
In the present cohort, 4 different sets of diagnostic criteria (DSMIV,
ICD-10, ADDTC, NINDS-AIREN) were considered for the diagno-
sis of VaD. The diagnosis was performed using a 2-step procedure:
(1) diagnosis of dementia and (2) association of the dementia to
lesions of vascular origin.
Diagnosis of Dementia
For the DSM IV, ICD-10, and standard NINDS-AIREN criteria for
VaD, although slight differences in its formulation, the diagnosis of
dementia in each patient was made by 1 of 2 expert neurologists,
after discussion and agreement with the neuro-psychologist who
performed the cognitive testing, according to a unique definition
based on the DSM IV criteria for dementia.2
For the modified NINDS-AIREN research criteria for SIVD,11 the
diagnosis of dementia was made separately based on available
neuropsychological data and using a criteria-based algorithm. This
definition of dementia includes a memory deficit that can be mild or
severe and characterized by impaired recall, relative intact recogni-
tion, less severe forgetting, and benefit from cues, and a dysexecu-
tive syndrome. This cognitive deficit should interfere with complex
(executive) activities of daily living and not be attributable to
physical effects of the cerebrovascular disease alone. Thus, in the
present study, a patient was considered to be demented when
presenting with a cognitive deficit characterized by reduced perfor-
mances (z scores 1.65) for the total free recall (memory impair-
ment) of the Grober and Buschke procedure and for at least 2 of the
following tests of executive function: Similarities, Cubes, Trail
Making Test B, verbal fluency, or 6 criteria found with the
Wisconsin test. Additionally, these cognitive alterations had to be
associated with at least 2 impaired instrumental activities of daily
living as reflected by IADL score 6 (IADL items were preferred to
ADL items because they are altered earlier in the course of
dementia27).
Attribution of Dementia to Lesions of Vascular
Origin According to DSMIV, ICD 10, ADDTC,
NINDS-AIREN, and Modified NINDS-AIREN
Diagnostic Criteria of VaD
The different set of criteria considered in this study require various
neuroimaging evidence of cerebrovascular disease, focal neurologi-
cal signs, or history of stroke with a temporal relationship with
dementia. DSM IV criteria for VaD require only neuroimaging
evidence of cerebrovascular disease judged to be etiologically related
to cognitive alterations.2
ICD10 criteria for VaD require neuroimaging evidence of cere-
brovascular disease “reasonably judged to be etiologically related to
dementia” and the presence of focal neurological findings such as
unilateral spastic weakness of the limb, unilaterally increased tendon
reflexes, extensor plantar response, or pseudobulbar palsy.4
The ADDTC criteria for possible VaD include clinical and
neuroimaging evidence of Binswanger disease, but without any
specification for this “evidence.”28 To avoid redundancy with other
sets of criteria in the absence of clear definition of “Binswanger’s
disease,” we chose not to include these criteria in the present
analysis.
According to the standard NINDS-AIREN criteria,5 the diagnosis
of probable VaD in patients with dementia requires the following
conditions: (1) presence of focal signs at neurological examination
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such as hemiparesis, lower facial weakness, Babinski sign, sensory
deficit, hemianopia, or dysarthria; (2) evidence of a temporal
relationship between the onset of dementia and stroke or an abrupt
deterioration or fluctuating/stepwise course; and (3) presence on
brain imaging of extensive periventricular white matter lesions
involving at least 25% of the total white matter or multiple basal
ganglia and white matter lacunes.
Finally, the NINDS-AIREN modified research criteria for subcor-
tical ischemic vascular dementia11 require clinical evidence of
cerebrovascular disease, ie, focal signs such as hemiparesis, lower
facial weakness, Babinski sign, sensory deficit, dysarthria, gait
disorders, extrapyramidal signs (others signs such as early urinary
symptoms, behavioral symptoms, dysphagia were considered to
“support” the diagnosis; and brain imaging evidence of cerebrovas-
cular disease. Two types of cases were distinguished by visual
assessment on MRI: (1) predominantly white matter cases charac-
terized by extending periventricular and deep white matter lesions:
extending caps or irregular halo (10 mm broad) and diffuse
confluent hyperintensities (25 mm) and at least 1 lacunar infarct in
the deep gray matter; and (2) predominant “lacunar cases” in which
multiple lacunes 5 in the deep gray matter were associated with at
least moderate white matter lesions.
Statistical Procedure
The different percentages of patients satisfying the various sets of
diagnostic criteria for dementia as well as for vascular dementia were
estimated in the whole cohort. The sample of patients satisfying at
least one set of criteria for dementia was considered as the reference
population for analysis of sensitivity. This population, the largest
sample with demented subjects (to reduce bias related to the
definition of dementia), was chosen to compare different sets of
diagnostic criteria.
The results obtained after using the diagnostic criteria for demen-
tia are presented first with the main clinical characteristics of the
demented population. Thereafter, the MRI and clinical features of
demented patients are detailed according to the different sets of
diagnostic criteria. The distribution of vascular dementia and con-
cordance between these sets of criteria (for each pair of sets,
percentage of patients satisfying both criteria) are then reported.
Results
Diagnosis of Dementia
Among the 115 patients included in the study, 23 (20%)
subjects fulfilled the DSM IV criteria for dementia and 28
(24%) patients satisfied the conditions of the modified
NINDS-AIREN criteria of dementia for SIVD (Table 1).
Note that 34 patients who had significant impairment in
executive functions did not have dementia (29% of the whole
cohort). There were 22 overlapping cases between these sets
of criteria and a total of 29 patients who satisfied either the
first set of criteria or the second (concordance between the 2
definitions on the whole cohort of 94%). This group of 29
patients served as the reference group for sensitivity analysis.
Their mean age was 628.8 years (50.811.3 years in the
group of patients without dementia), and sex ratio (M/F) was
2.2 (0.8 in the group of patients without dementia). Only a
single patient was considered to be demented according to
DSM IV criteria but did not fulfill the algorithm derived from
the modified NINDS-AIREN criteria of dementia for SIVD
(this case did not show any significant impairment of total
free recall). Six patients without dementia according to DSM
IV criteria fulfilled the conditions required in the modified
NINDS-AIREN criteria for SIVD (“nonoverlapping cases”).
Average scores of these patients for global cognitive scales
and IADL are presented in Table 2. Among the 22 overlap-
ping cases, 15 (70%) had a severe disability (IADL 1),
whereas the IADL was 4 in only 2 patients (8%). In
contrast, for 4 out of the 6 “nonoverlapping cases,” the IADL
was 4 and none had IADL 1.
Attribution of Dementia to Lesions of Vascular
Origin According to DSMIV, ICD 10,
NINDS-AIREN, and Modified NINDS-AIREN
Diagnostic Criteria of VaD
In our cohort, all 29 patients who satisfied at least 1 set of
diagnostic criteria for dementia presented on MRI with
extensive white matter lesions of vascular origin. Therefore,
all CADASIL patients fulfilling the DSM IV criteria for
dementia (n23) were considered to satisfy the DSMIV
criteria of VaD. Among them, 21 patients also had a pyram-
idal syndrome or pseudobulbar palsy and thus satisfied the
ICD10 criteria. Finally, only 13 of them had a clinical history
of stroke associated with focal signs and consequently satis-
fied the standard NINDS-AIREN criteria of probable VaD
(Table 3). Thus, in this group of 23 patients with dementia,
the sensitivity of the DSM IV , ICD 10, and standard
NINDS-AIREN criteria for VaD was, respectively, 100%,
91%, and 56%.
All 28 patients satisfying the modified NINDS-AIREN
criteria of dementia for SIVD presented with extending caps
and confluent hyperintensities in the white matter and at least
1 lacunar infarct in the deep gray matter (range of total
number of lacunes from 2 to 39). Thus, all fulfilled the
imaging criteria of the modified NINDS-AIREN definition of
SIVD and could be considered as “predominantly white
Table 1. Diagnosis of Dementia According to the DSMIV
Criteria and to the Definition of the Modified NINDS-AIREN
Criteria for SIVD in 115 CADASIL Patients
n (%)
DSM IV dementia criteria 23 (20)
Cognitive syndrome described in the modified
NINDS-AIREN criteria for SIVD
28 (24)
z score 1.65 for total free recall of the Grober procedure 38 (33)
z score 1.65 in 2 tests for dysexecutive syndrome 62 (54)
IADL 6 34 (29)
Concordance (% of overlapping cases with and without
dementia)
108/115 (94)
The % was obtained on the whole population.
Table 2. Average Scores of MMSE, MDRS, and IADL (mean
valueSD, range) in Patients Satisfying Both DSMIV and
Modified NINDS-AIREN Criteria of Dementia and in Patients
Only Satisfying the Modified NINDS-AIREN Criteria of Dementia
DSMIV and Modified NINDS-AIREN
Criteria of Dementia (n22)*
Only Modified NINDS-AIREN
Criteria of Dementia (n6)
MMSE 16.45.7 26.63.4
MDRS 84.927.3 1199.5
IADL 0.871.63 4.31.2
*MMSE scores and MDRS were obtained in only 15 of the patients with
dementia. Eight subjects were too severely disabled to complete the tasks
(27% of all patients with dementia).
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matter” cases. However, the complete modified NINDS-
AIREN criteria for SIVD were fulfilled by only 26 out of the
28 patients because 2 patients did not show any focal signs at
neurological examination. Thus, in this group of 28 patients
with dementia, the sensitivity of the modified NINDS-
AIREN criteria for SIVD was 93%. In addition, 29 out of 86
(33%) CADASIL patients without dementia also fulfilled the
imaging diagnostic criteria of SIVD in the present cohort.
If the whole group of patients with dementia was consid-
ered as the reference group (n29), the overall sensitivity of
the DSM IV, ICD 10, standard NINDS-AIREN criteria for
VaD, and for modified NINDS-AIREN criteria for SIVD
was, respectively, 79%, 72%, 45%, and 90%.
The detailed results at the individual level after the appli-
cation of the different sets of diagnostic criteria are presented
in Figure. The concordance between the different sets of
criteria was incomplete and varied between 86% and 98.2%
as detailed in Table 4. This incomplete concordance is
illustrated at the individual level by Figure. Finally, the
associated clinical features in demented patients according to
the modified NINDS-AIREN criteria are detailed in Table 5.
Gait disturbances and pyramidal signs were detected in 92%
of this population, whereas focal deficits such as sensory or
visual field defects were detected in 12%.
Discussion
In this study, we applied different sets of diagnostic criteria of
VaD to a cohort of 115 CADASIL patients who were at
various stages of the disease. Our study shows that, in a large
population of patients with subcortical brain lesions of
vascular origin, dementia as defined by the modified criteria
for SIVD is observed in a larger population than dementia as
defined by the DSMIV criteria, mainly developed for the
diagnosis of Alzheimer disease. In addition, in the demented
patients satisfying both sets of criteria, 70% of subjects had
a severe disability. In contrast, none of those exclusively
diagnosed by the modified criteria for SIVD (“nonoverlap-
ping cases”) had a similar status and two-thirds had IADL
4. Such results suggest that the subcriteria for dementia
derived from the modified NINDS-AIREN criteria for SIVD
are more sensitive than the DSMIV criteria to early stages of
dementia occurring in a small vessel disease of the brain.
These data also emphasize the importance of executive
dysfunction in the clinical expression of SIVD, and further
confirm that the traditional definition of dementia focused on
memory impairment is actually too “Alzheimerized”30 for
dementia caused by small vessel diseases.31 In addition, in the
present study, the use of both sets of criteria of dementia
circumscribed less than one-third of the cohort patients. Most
of them were at an advanced stage of the disease and 27%
patients were even unable to complete the cognitive evalua-
tion because they were too severely impaired. Of note, about
one third of subjects in the cohort were outside the demented
group but had significant executive alterations in the absence
of severe disability. This group of patients may fall within the
recently individualized category designated as “vascular mild
cognitive impairment.”31,32
The use of a cut-off value for global cognitive scales is a
frequent alternative approach to the diagnosis of dementia,
particularly in large-scale studies. Herein, the data showed
that the mean Mini-Mental State Examination score of
demented patients at the early stage of dementia (nonover-
lapping cases satisfying only the modified NINDS-AIREN
criteria) is 26.6, beyond the usually accepted cut-off score of
24 used for dementia in degenerative disorders.33 Conversely,
the mean Mattis Dementia Rating Scale score of these
subjects was below the usual cut-off score of 127 found in the
literature.34.The underestimation of executive dysfunction in
the Mini-Mental State Examination compared with the Mattis
Dementia Rating Scale may explain this discrepancy. These
results support that the Mattis Dementia Rating Scale, used as
a global scale, should be preferred to delineate the group of
subjects with dementia in CADASIL and, probably, in other
small vessel disorders.
Table 3. Diagnosis of VaD According to Different Sets of Criteria in 115 CADASIL Patients
VaD Criteria DSM IV Criteria ICD-10 Criteria Standard NINDS-AIREN Criteria Modified SIVD NINDS-AIREN Criteria
Definition of dementia Cognitive deterioration with memory impairment, IADL impaired Memory deficit,* dysexecutive
syndrome,* IADL impaired*
Attribution of dementia to
lesions of vascular origin
Neuroimaging evidence of CVD (NS) Neuroimaging evidence of CVD
such as extensive WML or
multiple basal ganglia and WM
lacunar infarcts and history of
stroke and temporal
relationship
Extensive WML and l lacune in
deep gray matter or multiple deep
gray matter lacunar infarcts
Focal Signs (NS)
Focal Signs
(pyramidal signs) Focal Signs†
N of patients 23 21 13 26
Total with dementia, % 79 72 45 90
Total patients, % 20 18 11 23
CVD indicates cerebrovascular disease; NS, not specified; WML, white matter lesions.
*z score 1.65 for total free recall of the Grober procedure.
z score 1.65 in 2 tests for dysexecutive syndrome.
IADL 6.
†Focal signs among the following: hemiparesis, pyramidal signs, sensory deficit, dysarthria, gait disorders, and extrapyramidal signs.
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The application of different sets of VaD diagnostic criteria
in the CADASIL cohort resulted in incompletely overlapping
groups as previously reported in different populations.6–9 The
DSM IV and ICD-10 criteria for VaD, as well as the standard
NINDS-AIREN criteria, were found to be of variable sensi-
tivity in demented patients with CADASIL. The comparison
of the Standard NINDS-AIREN criteria for VaD and the
modified research ones for SIVD showed that the latter
criteria significantly increase the diagnostic sensitivity, which
remains, however, 100%. The positive “history of stroke”
when used as a criterion was responsible for the poor
sensitivity of the NINDS-AIREN definition of probable VaD
in our population. In contrast to some subtypes of VaD such
as multi-infarct VaD or poststroke dementia,1 for which this
criterion is a prerequisite, its use in CADASIL patients
appears less valid because the cognitive decline may be
progressive and independent of stroke events.35 In addition,
our data also show that although the presence of focal signs
of stroke was present in most demented subjects , 2 cases did
not fulfill the modified NINDS-AIREN criteria for SIVD
because of the lack of any focal deficit. These results are in
line with those of Pohjaswaara et al36 who previously re-
ported that patients with sporadic SIVD can present without
any focal signs of stroke. This suggests that this criterion
should be considered as a supportive symptom rather than as
a prerequisite in the definition of SIVD. Interestingly, we also
observed that the presence of gait disorders and pyramidal
symptoms was much more frequent than sensory deficits or
visual field defects in CADASIL patients, which suggests that
all focal symptoms of stroke are not of equivalent sensitivity
for defining SIVD.
Imaging criteria are also considered for diagnosis of VaD.
In our cohort, all patients with dementia showed extensive
white matter lesions and at least 1 lacunar infarct in the deep
gray matter as required in the “Binswanger type” definition of
SIVD. Extensive white matter lesions on T2 and FLAIR are
significantly correlated with clinical severity or executive
performances in small vessel diseases.37 However, they may
be insufficiently discriminating for the diagnosis of dementia.
In a population of poststroke elderly patients, Ballard et al29
observed that the amount of white matter lesions, and the
cut-off built into the standard NINDS-AIREN imaging crite-
ria, did not discriminate between patients with and without
dementia. In the present cohort, both extensive white matter
lesions and the presence of a lacunar infarct were detected in
one-third of patients without dementia, which further sup-
ports that the NINDS-AIREN imaging criteria of SIVD have
poor specificity in this subtype of dementia. The total amount
of lacunar lesions and also the degree of atrophy were
recently found to be the most potent imaging predictors of
cognitive impairment in CADASIL.24,25,38 Further studies
may help to determine whether a detailed analysis of location
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Figure. Distribution of vascular dementia according to the differ-
ent set of criteria. *Note that 1 patient satisfying only the modi-
fied NINDS-AIREN criteria for dementia but not the complete
criteria for SIVD is not included here.
Table 4. Concordance Between Criteria for the Diagnosis of
Vascular Dementia in 115 CADASIL Patients
Applied Criteria Concordance %
DSM IV/ICD 10 98.2
DSM IV/standard NINDS-AIREN for probable VaD 91.3
DSM IV/modified NINDS-AIREN for SIVD 95.6
ICD 10/standard NINDS-AIREN for probable VaD 93
ICD 10/modified NINDS-AIREN for SIVD 93
Standard NINDS-AIREN for probable VaD/
modified NINDS-AIREN for SIVD
86
Table 5. Clinical Features of Patients Satisfying the Modified
NINDS-AIREN Criteria for SIVD (n26)
Modified NINDS-AIREN Criteria
for SIVD, n26 (%)
Pyramidal signs 24 (92)
Gait disorders 24 (92)
Urinary disorders 21 (80)
Clinical history of 1 stroke 15 (57)
Dysarthria 14 (54)
Swallowing problems 10 (38)
Extrapyramidal symptoms 5 (19)
Sensory deficit 3 (11)
Visual field defect 2 (7)
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of small deep infarcts, the exact measurement of their load, or
the estimation of cerebral atrophy can further improve the
diagnosis of SIVD.39
The main limitation of this study concerns the small
number of patients with dementia recruited in the cohort.
However, this is compensated by the strong homogeneity of
the group of patients having an identical vascular disease. In
the absence of consensus in the definition of dementia, the
calculation of sensitivity required the choice of a reference
population for patients with dementia (the largest sample of
demented subjects in the present study). Another limitation of
this study is that specificity of SIVD criteria could not be
determined herein because we evaluated diagnostic criteria in
a population with all patients having a vascular disorder.
Other populations with dementia but without vascular disor-
ders are needed for this purpose.
Conclusion
In conclusion, our results demonstrate that the modified
NINDS-AIREN criteria proposed for SIVD actually improve
the diagnosis of VaD related to small vessel diseases and
suggest that some refinements may further improve its
sensitivity. The present data suggest that some clinical
features such as a positive history of stroke or presence of
focal signs should not be mandatory for diagnosis of SIVD. In
contrast, whether new imaging features such as the load of
lacunar infarctions, the location of such lesions, or estimation
of the degree of atrophy may improve the diagnosis of SIVD
will need further investigation.
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